Cathy Creswell1,2, Maaike H Nauta3, Jennifer L Hudson4, Sonja March5, Tessa Reardon1,2, Kristian Arendt6, Denise Bodden7, Vanessa E Cobham8,9, Caroline Donovan10, Brynjar Halldorsson1,2,11, Tina In-Albon12, Shin-Ichi Ishikawa13, Daniel Bach Johnsen6, Maral Jolstedt14,15, Rachel de Jong3, Leonie Kreuze3, Lynn Mobach4,16, Ronald M Rapee4, Susan H Spence10,17, Mikael Thastum6, Elisabeth Utens18,19, Sarah Vigerland14,15, Gro Janne Wergeland20,21, Cecilia A Essau22, Anne Marie Albano23, Brian Chu24, Muniya Khanna25, Wendy K Silverman26, Philip C Kendall27. 1. Department of Experimental Psychology, University of Oxford, Oxford, UK. 2. Department of Psychiatry, University of Oxford, Oxford, UK. 3. Department of Clinical Psychology and Experimental Psychopathology, University of Groningen, Groningen, The Netherlands. 4. Department of Psychology, Centre for Emotional Health, Macquarie University, Sydney, NSW, Australia. 5. School of Psychology and Counselling, University of Southern Queensland, Springfield, QLD, Australia. 6. Cognitive Therapy Centre Aarhus, Aarhus, Denmark. 7. Department of Child and Adolescent Studies, Utrecht University, Utrecht, The Netherlands. 8. Children's Health QLD Child and Youth Mental Health Service, Brisbane, QLD, Australia. 9. School of Psychology, The University of Queensland, Brisbane, QLD, Australia. 10. School of Applied Psychology, Griffith University, Brisbane, QLD, Australia. 11. Department of Psychology, Reykjavik University, Reykjavik, Iceland. 12. Clinical Child and Adolescent Psychology and Psychotherapy Unit, University of Koblenz and Landau, Landau, Germany. 13. Faculty of Psychology, Doshisha University, Kyoto, Japan. 14. Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden. 15. Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden. 16. Behavioural Science Institute, Radboud University, Nijmegen, The Netherlands. 17. Australian Institute for Suicide Research and Prevention, Griffith University, Brisbane, QLD, Australia. 18. Research Institute of Child Development and Education, University of Amsterdam / The Bascule / Amsterdam UMC, Amsterdam, The Netherlands. 19. Sophia Children's Hospital, Erasmus Medical Centre, Rotterdam, The Netherlands. 20. Division of Psychiatry, Department of Child and Adolescent Psychiatry, Haukeland University Hospital, Bergen, Norway. 21. Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway. 22. Department of Psychology, University of Roehampton, London, UK. 23. Columbia University Irving Medical Center, Columbia University, New York, NY, USA. 24. Department of Clinical Psychology, Rutgers, The State University of New Jersey, Piscataway, NJ, USA. 25. Children's Hospital of Philadelphia, Philadelphia, PA, USA. 26. Child Study Center, Yale University School of Medicine, New Haven, CT, USA. 27. Department of Psychology, Temple University, Philadelphia, PA, USA.
Abstract
BACKGROUND: Anxiety disorders in children and young people are common and bring significant personal and societal costs. Over the last two decades, there has been a substantial increase in research evaluating psychological and pharmacological treatments for anxiety disorders in children and young people and exciting and novel research has continued as the field strives to improve efficacy and effectiveness, and accessibility of interventions. This increase in research brings potential to draw together data across studies to compare treatment approaches and advance understanding of what works, how, and for whom. There are challenges to these efforts due largely to variation in studies' outcome measures and variation in the way study characteristics are reported, making it difficult to compare and/or combine studies, and this is likely to lead to faulty conclusions. Studies particularly vary in their reliance on child, parent, and/or assessor-based ratings across a range of outcomes, including remission of anxiety diagnosis, symptom reduction, and other domains of functioning (e.g., family relationships, peer relationships). METHODS: To address these challenges, we convened a series of international activities that brought together the views of key stakeholders (i.e., researchers, mental health professionals, young people, parents/caregivers) to develop recommendations for outcome measurement to be used in treatment trials for anxiety disorders in children and young people. RESULTS AND CONCLUSIONS: This article reports the results of these activities and offers recommendations for selection and reporting of outcome measures to (a) guide future research and (b) improve communication of what has been measured and reported. We offer these recommendations to promote international consistency in trial reporting and to enable the field to take full advantage of the great opportunities that come from data sharing going forward. 2020 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for Child and Adolescent Mental Health.
BACKGROUND:Anxiety disorders in children and young people are common and bring significant personal and societal costs. Over the last two decades, there has been a substantial increase in research evaluating psychological and pharmacological treatments for anxiety disorders in children and young people and exciting and novel research has continued as the field strives to improve efficacy and effectiveness, and accessibility of interventions. This increase in research brings potential to draw together data across studies to compare treatment approaches and advance understanding of what works, how, and for whom. There are challenges to these efforts due largely to variation in studies' outcome measures and variation in the way study characteristics are reported, making it difficult to compare and/or combine studies, and this is likely to lead to faulty conclusions. Studies particularly vary in their reliance on child, parent, and/or assessor-based ratings across a range of outcomes, including remission of anxiety diagnosis, symptom reduction, and other domains of functioning (e.g., family relationships, peer relationships). METHODS: To address these challenges, we convened a series of international activities that brought together the views of key stakeholders (i.e., researchers, mental health professionals, young people, parents/caregivers) to develop recommendations for outcome measurement to be used in treatment trials for anxiety disorders in children and young people. RESULTS AND CONCLUSIONS: This article reports the results of these activities and offers recommendations for selection and reporting of outcome measures to (a) guide future research and (b) improve communication of what has been measured and reported. We offer these recommendations to promote international consistency in trial reporting and to enable the field to take full advantage of the great opportunities that come from data sharing going forward. 2020 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for Child and Adolescent Mental Health.
Authors: Tessa Reardon; Obioha C Ukoumunne; Mara Violato; Susan Ball; Paul Brown; Tamsin Ford; Alastair Gray; Claire Hill; Bec Jasper; Michael Larkin; Ian Macdonald; Fran Morgan; Jack Pollard; Michelle Sancho; Falko F Sniehotta; Susan H Spence; Paul Stallard; Jason Stainer; Lucy Taylor; Victoria Williamson; Emily Day; Jennifer Fisk; Iheoma Green; Gemma Halliday; Ciara Hennigan; Samantha Pearcey; Olly Robertson; Cathy Creswell Journal: Trials Date: 2022-10-22 Impact factor: 2.728
Authors: Anke M Klein; Juliette M Liber; Natasja D J van Lang; Catrien Reichart; Maaike Nauta; Brigit M van Widenfelt; Elisabeth M W J Utens Journal: Res Child Adolesc Psychopathol Date: 2021-06-24